HCAL
STLN icon

HURRICANE CAPITAL ADVISORS LLC’s Starling Oncology STLN Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$30.7K – 938
2026
Q1 		$30.7K Buy
+10,000
New +$30.7K 0.01% 542

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wexford Capital
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's STLN Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 10,000 shares — an estimated $30.7K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in STLN in Q1 2026 and held it in 1 quarter. The position peaked at $30.7K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 10,000 Starling Oncology shares in Q2 2026, an estimated $30.7K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Starling Oncology in Q1 2026 and held it in 1 quarter.
  • HURRICANE CAPITAL ADVISORS LLC's Starling Oncology position peaked at $30.7K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.